Abstract:Nanoparticles (NPs) have been used in numerous applications as anticancer, antibacterial and antioxidant agents. Artificial engineering of protein interactions with NPs in biological systems is crucial to develop potential NPs for drug delivery and cancer nanotherapy. The protein corona (PC) on the NP surface, displays an interface between biomacromolecules and NPs, governing their pharmacokinetics and pharmacodynamics. Upon interaction of proteins with the NPs, their surface features are modified and they can easily be removed from the circulation by the mononuclear phagocytic system (MPS). PC properties heavily depend on the biological microenvironment and NP physicochemical parameters. Based on this context, we have surveyed different approaches that have been used for artificial engineering of the PC composition on NP surfaces. We discussed the effects of NP size, shape, surface modifications (PEGylation, self-peptide, other polymers), and protein pre-coating on the PC properties. Additionally, other factors including protein source and structure, intravenous injection and the subsequent shear flow, plasma protein gradients, temperature and local heat transfer, and washing media were considered in the context of their effects on the PC properties and overall target cellular effects. Moreover, the effects of NP-PC complexes on cancer cells based on cellular interactions, organization of intracellular PC (IPC), targeted drug delivery (TDD) and regulation of burst drug release profile of nanoplatforms, enhanced biocompatibility, and clinical applications were discussed followed by challenges and future perspective of the field. In conclusion, this paper can provide useful information to manipulate PC properties on the NP surface, thus trying to provide a literature survey to shorten their shipping from preclinical to clinical trials and to lay the basis for a personalized PC.

The impact of protein corona on the biological behavior of targeting nanomedicines

Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy

The Impact of Protein Corona on the Behavior and Targeting Capability of Nanoparticle-Based Delivery System.

The protein corona and its effects on nanoparticle-based drug delivery systems

Nanoparticle protein corona: from structure and function to therapeutic targeting

The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Towards understanding of nanoparticle–protein corona

The role of protein corona on nanodrugs for organ-targeting and its prospects of application

Protein Corona: Challenges and Opportunities for Targeted Delivery of Nanomedicines

The Janus of Protein Corona on Nanoparticles for Tumor Targeting, Immunotherapy and Diagnosis

The Interaction Between Nanoparticles-Protein Corona Complex and Cells and Its Toxic Effect on Cells

Interplay Between Nanomedicine And Protein Corona

Characterization and Biomedical Application Opportunities of the Nanoparticle's Protein Corona

A health concern regarding the protein corona, aggregation and disaggregation

Protein corona on brain targeted nanocarriers: Challenges and prospects

Emerging Well-Tailored Nanoparticulate Delivery System Based on in Situ Regulation of the Protein Corona

Protein corona, influence on drug delivery system and its improvement strategy: A review

Perspectives on Protein-Nanoparticle Interactions at the <i>In Vivo</i> Level

The protein corona from nanomedicine to environmental science

The Yin and Yang of the protein corona on the delivery journey of nanoparticles

Looking back, moving forward: protein corona of lipid nanoparticles